Allspring Global Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-248,201
Closed -$61M 2973
2022
Q3
$61M Sell
248,201
-4,046
-2% -$1.09M 0.11% 244
2022
Q2
$62.4M Sell
252,247
-6,967
-3% -$1.88M 0.1% 251
2022
Q1
$85.9M Sell
259,214
-13,897
-5% -$4.28M 0.11% 250
2021
Q4
$98.1M Buy
+273,111
New +$92.3M 0.11% 248

Other funds holding ABMD

Allspring Global Investments's ABMD Position: Q4 2022 in Review

Allspring Global Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 248,201 shares — an estimated $61M sold.

Allspring Global Investments first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $98.1M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Allspring Global Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 248,201 Abiomed Inc shares in Q4 2022, an estimated $61M.
  • Allspring Global Investments first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Abiomed Inc position peaked at $98.1M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.